The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of ...

BUFFALO, N.Y. — In January, Nicole Albanese, PharmD, clinical associate professor of pharmacy practice in the University at ...

The advertising watchdog National Advertising Division said Wednesday that Apple advertising claimed Apple Intelligence ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

This three-bed, two-and-a-half bath, 1,750-square-foot craftsman home in La Grange’s Artisan Park neighborhood was built in ...

The podcast's founder chats with WWD about how his COVID-19 pandemic passion project attracted the gotha of design, art, fashion, travel, food and more.

He removed all promotional posts, paid partnerships and advertisements from his Instagram grid and placed them under the reels section. The ‘posts’ section will have updates about his personal ...

After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock is, again, testing multiyear lows. The $700 billion pharmaceutical giant ...

The quotes from a school library book, though offensive words were disguised, the offensive content conveyed was too graphic to print. The newspaper, like school boards across the country refusing ...

Lilly claims Premier Weight Loss is selling altered versions of Lilly's weight loss drugs Zepbound and Mounjaro. In the lawsuit, Lilly alleges Premier Weight Loss is falsely marketing Lilly's products ...

Medicare coverage for anti-obesity drugs was not finalized, affecting drugs like Wegovy and Zepbound. Covering weight loss drugs may cost $35 billion from 2026–2034, with estimated savings under ...